Biografi/ Biography :
Shamin is a senior lecturer at the Faculty of Pharmacy, UKM. He earned his BPharm, Postgraduate Certificate in Pharmacy (PgCertPharm), and Ph.D. all from the University of Otago.
Since 2018, Shamin has been serving as a senior lecturer, concentrating his research on clinical pharmacology & pharmacometrics and evidence synthesis in pharmacotherapy.
His research involves developing bioanalytical drug assays using HPLC, along with computational modeling and simulation of pharmacokinetics and pharmacometrics models. Software tools used are MATLAB, R, NONMEM, Monolix, and Jamovi.
Dedicated to improving treatment through scientific evidence, Shamin has actively participated in evidence-based pharmacotherapies research, with more than 10 publications using systematic review and meta-analyses methodologies. His current research spans anticoagulants (warfarin and NOACs), immunoglobulin G, asparaginase, methotrexate, and vitamin D. Recently he developed an interest in researching the use of Machine Learning to improve medication use.
In addition to his academic role, Shamin continues to practice as a community pharmacist, bridging the gap between academia and practical experience.
shamin bin mohd saffian;mohd bin makmor bakry;nurasyikin binti yusof. (2024). safety, efficacy and variability of dabigatran therapy in malaysian patients. - . .
yan qi tan, c-khai loh, shamin mohd saffian, suzana makpol. (2024). improved hplc method with automated pre-column sample derivatisation for serum pegylated l-asparaginase activity measurement in paediatric acute lymphoblastic leukaemia patients. - journal of pharmaceutical and biomedical analysis. 1-9.
mohd bin makmor bakry;raha binti abdul rahman;farida hanim binti islahudin;rufinah teo;shamin bin mohd saffian. (2023). roles of mdr1 and oprm1 gene polymorphisms on pharmacodynamics of propofol-remifentanil total intravenous anaesthesia (tiva) in pediatric surgery. - . .
wan haslina binti wan abdul halim;mae-lynn catherine bastion;mohd bin makmor bakry;adliah binti mhd ali;mushawiahti binti mustapha;noraida binti mohamed shah;othmaliza binti othman;norshamsiah binti md. din;mazlina binti mohd said;shamin bin mohd saffian. (2023). the pharmacokinetics of topical levofloxacin 1.5% vs topical moxifloxacin 0.5%. - . .
munirah jamal, jameela sathar, jamaliah jamari, shamin mohd saffian. (2023). a comparison of the incidence rate for joint bleeding and fviii consumption between on-demand versus prophylaxis factor viii replacement therapy and the direct cost of prophylaxis treatment in severe haemophilia a patients. - malaysian journal of medical sciences. 129-136.
yan qi tan, c-khai loh, shamin mohd saffian, suzana makpol. (2024). improved hplc method with automated pre-column sample derivatisation for serum pegylated l-asparaginase activity measurement in paediatric acute lymphoblastic leukaemia patients. - journal of pharmaceutical and biomedical analysis. 1-9.
hock peng koh, adyani md redzuan, shamin mohd saffian, hasnita hassan, jivanraj r. nagarajah, noel thomas ross. (2023). mortality outcomes and predictors of failed thrombolysis following stemi thrombolysis in a non-pci capable tertiary hospital: a 5-year analysis. - internal and emergency medicine. 1169-1180.
shamin mohd saffian, jian lynn lee, makmor-bakry mohd, farida islahudin, noraida mohamed shah. (2022). population pharmacokinetic modeling of intravenous immunoglobulin in patients with immune system disorders. - cpt: pharmacometrics & systems pharmacology. S13.
hock peng koh, adyani md redzuan, shamin mohd saffian, jivanraj nagarajah, noel thomas ross, hasnita hassan. (2022). impact of covid-19 pandemic on stemi thrombolysis and emergency department's performance in a non-pci capable tertiary hospital. - american journal of emergency medicine. 9-14.
shamin mohd saffian, nor aini jamil, nor asyikin mohd tahir, ernieda hatah. (2022). vitamin d insufficiency is high in malaysia: a systematic review and meta-analysis of studies on vitamin d status in malaysia. - frontiers in nutrition. 1-13.
hock peng koh, adyani md redzuan, shamin mohd saffian, jivanraj r. nagarajah, noel thomas ross, hasnita hassan. (2022). the outcomes of reperfusion therapy with streptokinase versus tenecteplase in st-elevation myocardial infarction (stemi): a propensity-matched retrospective analysis in an asian population. - international journal of clinical pharmacy. 641-650.
z zainal abidin, za zainuren, e noor, ns mohd nor, s mohd saffian, r abdul halim. (2021). periodontal health status of children and adolescents with diabetes mellitus: a systematic review and meta-analysis. - australian dental journal. S15-S26.
nor asyikin mohd tahir, shamin mohd saffian, farida hanim islahudin, abdul halim abdul gafor, hanita othman, hamizah abdul manan, mohd makmor-bakry. (2020). effects of cst3 gene g73a polymorphism on cystatin c in a prospective multiethnic cohort study. - nephron. 204-212.
nor asyikin mohd tahir, abdul halim abdul gafor, farida hanim islahudin, shamin mohd saffian, hamizah abdul manan, hanita othman, mohd makmor-bakry. (2018). agreement between creatinine and cystatin c-based equations in the estimation of glomerular filtration rate among malaysian patients with renal impairment. - indian journal of pharmaceutical education and research. .
yan qi tan, c-khai loh, shamin mohd saffian, suzana makpol. (2024). improved hplc method with automated pre-column sample derivatisation for serum pegylated l-asparaginase activity measurement in paediatric acute lymphoblastic leukaemia patients. - journal of pharmaceutical and biomedical analysis. 1-9.
adyani md redzuan, nur syazwani taridi, farida hanim islahudin, shamin mohd saffian, siti azdiah abdul aziz, mohd makmor bakry, yin mei kuen. (2023). assessment of serum digoxin concentration measurement in patients with heart failure and atrial fibrillation. - malaysian journal of medicine and health sciences. 7.
munirah jamal, jameela sathar, jamaliah jamari, shamin mohd saffian. (2023). a comparison of the incidence rate for joint bleeding and fviii consumption between on-demand versus prophylaxis factor viii replacement therapy and the direct cost of prophylaxis treatment in severe haemophilia a patients. - malaysian journal of medical sciences. 129-136.
kathleen b. olaco, shamin mohd saffian. (2023). physicochemical properties and recent modifications of sago (metroxylon sagu) starch for pharmaceutical and food applications: a scoping review. - malaysian journal of medicine and health sciences. 44-45.
hock peng koh, adyani md redzuan, shamin mohd saffian, hasnita hassan, jivanraj r. nagarajah, noel thomas ross. (2023). mortality outcomes and predictors of failed thrombolysis following stemi thrombolysis in a non-pci capable tertiary hospital: a 5-year analysis. - internal and emergency medicine. 1169-1180.
shamin bin mohd saffian;mohd bin makmor bakry;nurasyikin binti yusof. (2024). safety, efficacy and variability of dabigatran therapy in malaysian patients. - . .
wan haslina binti wan abdul halim;mae-lynn catherine bastion;mohd bin makmor bakry;adliah binti mhd ali;mushawiahti binti mustapha;noraida binti mohamed shah;othmaliza binti othman;norshamsiah binti md. din;mazlina binti mohd said;shamin bin mohd saffian. (2023). the pharmacokinetics of topical levofloxacin 1.5% vs topical moxifloxacin 0.5%. - . .
shamin mohd saffian. (2023). 1twenty80. - the d-f ender of health: a pharmacist's sunny side perspective on vitamin d. 26-30.
mohd bin makmor bakry;raha binti abdul rahman;farida hanim binti islahudin;rufinah teo;shamin bin mohd saffian. (2023). roles of mdr1 and oprm1 gene polymorphisms on pharmacodynamics of propofol-remifentanil total intravenous anaesthesia (tiva) in pediatric surgery. - . .
shamin mohd saffian. (2023). unlocking the tips and tricks for a good nights sleep. - 1twenty80. 28-31.
| Geran / Grant | Kolaborator / Collaborator | Status |
|---|---|---|
| KESAN KETAGIHAN DAN KETOKSIKAN BAHAN PSIKOAKTIF BAHARU (NPS) TERPILIH | jabatan siasatan jenayah narkotik, polis diraja malaysia | 36.1% (2023-11-01 sehingga 2026-12-31) |
| PROFILING THE PATTERN OF USE OF NEW PSYCHOACTIVE SUBSTANCES (NPS) IN MALAYSIA | agensi anti dadah kebangsaan | 40.3% (2024-05-15 sehingga 2025-11-14) |